Browse by Audience
MEMBER

Update Your Profile
Special Interest Groups (SIG)
Member Spotlights
IASP Connect
Join Now

RESEARCHER

PAIN
PAIN Reports
Pain Research Forum
Pain Researcher
Events

HEALTH CARE PROVIDER

Online Learning - PERC
Curricula
Graduate Opportunities
Treatment and Education Resources
Events

PATIENT & CAREGIVER

Resources for Living with Pain
Topic Pages
Free Videos
Events

PARTNER

Support IASP
Sponsor an Event
Become a Partner
Make a Donation

I am a
IASP Logo
Home I AM A Search Login

Papers of the Week

Home / Publications / Pain Research Forum / Papers of the Week / Safety, pharmacodynamic, and pharmacokinetic characterization of vericiguat: results from six phase I studies in healthy subjects.

< BACK TO ARCHIVE


2020 Oct 30


Eur J Clin Pharmacol


http://www.ncbi.nlm.nih.gov/pubmed/33125516?dopt=Abstract

Safety, pharmacodynamic, and pharmacokinetic characterization of vericiguat: results from six phase I studies in healthy subjects.

Authors

Safety, pharmacodynamic, and pharmacokinetic characterization of vericiguat: results from six phase I studies in healthy subjects.
Boettcher M, Thomas D, Mueck W, Loewen S, Arens E, Yoshikawa K, Becker C
Eur J Clin Pharmacol. 2020 Oct 30.
PMID: 33125516.

Abstract

To characterize the safety, pharmacodynamics, and pharmacokinetics (PK) of vericiguat in healthy males.
Read This Paper